阻塞性睡眠呼吸暂停低通气综合征与代谢综合征、脂联素、C反应蛋白相关性研究
|
摘要
目的:探讨阻塞性睡眠呼吸暂停低通气综合征(OSAHS)与代谢综合征(MS)的相关性。观察OSAHS病人血浆脂联素和C反应蛋白(CRP)水平,并分析OSAHS病人脂联素和C反应蛋白的水平与是否合并MS的相关性。
方法:通过多导睡眠监测诊断OSAHS,对20例对照组和43例OSAHS病人常规检查身高、体重,空腹血糖(FPG),餐后2小时血糖,血脂,空腹胰岛素(FINS),C反应蛋白水平(CRP)。应用ELASA方法测定血浆中脂联素水平。
结果:OSAHS病人与对照组之间体质指数、颈围、腰围不同(P<0.05),重度OSAHS病人白天有明显的嗜睡(P<0.05),重度OSAHS病人甘油三脂(TG)明显升高(P<0.05);中、重度OSAHS病人总胆固醇(CHO)水平高于对照组(P<0.05)。不同程度OSAHS病人血脂紊乱和高血压发生率不同(P<0.05),高血糖的发生率无明显差异,代谢综合征的发生率有统计学差异(P<0.05),重度OSAHS病人,MS的发生率增高(P<0.05)。OSAHS病人脂联素和C反应蛋白水平与对照组不同(P<0.05),中、重度OSAHS病人脂联素的水平低于轻度OSAHS病人,而C反应蛋白水平高于轻度OSAHS病人(P<0.05)。脂联素水平与最低血氧饱和度(LSAT)呈正相关,C反应蛋白水平与呼吸暂停低通气指数(AHI)呈正相关,与最低血氧饱和度(LSAT)呈负相关。OSAHS病人合并代谢综合征者脂联素水平更低,C反应蛋白水平更高(P<0.05)。
结论:OSAHS与MS具有相关性, OSAHS病人脂联素水平降低,CRP水平升高, LSAT越低,脂联素水平越低;AHI越高,LSAT越低,CRP水平越高。OSAHS合并MS病人脂联素水平更低,CRP水平更高,OSAHS与MS并存可能增加了心脑血管疾病的风险。
Background :The field of sleep apnea and other sleep-disordered breathing syndromes has been among the most rapidly evolving within the discipline of otolaryngology and head and neck surgery. An intrinsic sleep disorder that is often referred for an otolaryngologist’s evaluation is Obstructive sleep apnea hypopnea syndrome (OSAHS). Patients with OSAHS have an apnea-hypopnea index of more than five events per hour of sleep and usually have upper airway resistance and usually have accompanying loud snoring, sleep- disordered breathing, blood oxygen saturation decrease, excessive daytime sleepiness and other symptoms. Currently, OSAHS is considered to be the source of a variety of chronic systemic diseases. Insulin resistance is the pathophysiology foundation of Metabolic syndrome (MS). MS is composed of a series of syndromes such as hypertension, hyperglycemia, hyperlipemia and hyperuricacidemia, which are all risk factors of cardiovascular disease. MS is the most principal factor in the development of cardiovascular disease. More and more scholars have paid attention to the relationship between MS and OSAHS. Adiponectin levels and C-reactive protein (CRP) levels in serum are closely related to the metabolic syndrome. Adiponectin is one of the important regulatory factors in the regulation network of lipids metabolism and blood sugar homeostasis. It can reduce the level of blood sugar and blood fat and strengthen insulin resistance, anti-inflammatory and antagonistic role in atherosclerosis sclerosis. CRP level rising in serum can be used to assess the occurrence of acute complications and prognosis in atherosclerosis. Therefore, we can speculate that OSAHS may affect the adiponectin levels and CRP levels and the determination of adiponectin and CRP level may evaluate the risk of cardiovascular disease. In our study, we compared blood pressure, fasting serum glucose, blood fat, adiponectin, CRP in both OSAHS group and control group ,then discussed whether the obstructive sleep apnea hypopnea syndrome (OSAHS) was associated with the metabolic syndrome. Furthermore, we detected adiponectin levels and CRP levels in serum of OSAHS patients and analyzed whether their levels were relative to combined with MS.
Methods: According to apnea-hypopnea index (AHI), the OSAHS patients were divided into mild, moderate and severe groups: severe OSA (AHI>40, 21 males), moderate OSA (20 Results: Patients with OSAHS had higher BMI, waist circumference, neck circumference (P<0.05). The patients of severe group were significantly sleepy compared to other groups.(P<0.05). TG and CHO in each OSAHS group were different.(P<0.05). There was no significant difference among the mild, moderate and severe group in HDL-C (P>0.05). The severe group of OSAHS had higher TG levels.(P<0.05). CHO levels in severe and moderate group of OSAHS were different with other groups.(P<0.05)Patients with OSAHS suffered from hypertension and dyslipidemia. There was also significant difference among the mild, moderate and severe group with the development of OSAHS (P<0.05). Fasting blood glucose had no significant difference. The incidence of complicating the metabolic syndrome in patients with different pathogenetic condition had statistical differences(P<0.05). The complication of the metabolic syndrome in the severe group of OSAHS was much higher than that in other groups(P<0.05). It was found that the serum adiponectin levels were lower and CRP levels were higher in the subjects with OSAHS than that in those without OSAHS. Multiple stepwise regression analysis showed that the lowest arterial oxygen saturation was an independent risk factor resulting in the decrease of serum adiponectin levels while BMI and The apnea-hypopnea index value during sleep did not. The apnea-hypopnea index value was an independent risk factor resulting in the increase of serum CRP levels, while BMI and the lowest arterial oxygen saturation during sleep did not. Furthermore, among the patients with OSAHS, the serum adiponectin levels were lower and the CRP levels were higher in moderate and severe groups of OSAHS (P<0.05) , and the serum adiponectin levels were lower and the CRP level were higher with the complication of the metabolic syndrome than in those without metabolic syndrome (P <0.05).
Conclusions: We investigated whether the components of metabolic syndrome were associated with OSAHS in nonobese patients. OSAHS is associated with the components of metabolic syndrome and its overall prevalence. The serum adiponectin levels were lower and the CRP levels were higher with the complication of the metabolic syndrome in OSAHS . Therefore, the complication of metabolic syndrome may become an additive cardiovascular risk factor in subjects with OSAHS.
方法:通过多导睡眠监测诊断OSAHS,对20例对照组和43例OSAHS病人常规检查身高、体重,空腹血糖(FPG),餐后2小时血糖,血脂,空腹胰岛素(FINS),C反应蛋白水平(CRP)。应用ELASA方法测定血浆中脂联素水平。
结果:OSAHS病人与对照组之间体质指数、颈围、腰围不同(P<0.05),重度OSAHS病人白天有明显的嗜睡(P<0.05),重度OSAHS病人甘油三脂(TG)明显升高(P<0.05);中、重度OSAHS病人总胆固醇(CHO)水平高于对照组(P<0.05)。不同程度OSAHS病人血脂紊乱和高血压发生率不同(P<0.05),高血糖的发生率无明显差异,代谢综合征的发生率有统计学差异(P<0.05),重度OSAHS病人,MS的发生率增高(P<0.05)。OSAHS病人脂联素和C反应蛋白水平与对照组不同(P<0.05),中、重度OSAHS病人脂联素的水平低于轻度OSAHS病人,而C反应蛋白水平高于轻度OSAHS病人(P<0.05)。脂联素水平与最低血氧饱和度(LSAT)呈正相关,C反应蛋白水平与呼吸暂停低通气指数(AHI)呈正相关,与最低血氧饱和度(LSAT)呈负相关。OSAHS病人合并代谢综合征者脂联素水平更低,C反应蛋白水平更高(P<0.05)。
结论:OSAHS与MS具有相关性, OSAHS病人脂联素水平降低,CRP水平升高, LSAT越低,脂联素水平越低;AHI越高,LSAT越低,CRP水平越高。OSAHS合并MS病人脂联素水平更低,CRP水平更高,OSAHS与MS并存可能增加了心脑血管疾病的风险。
Background :The field of sleep apnea and other sleep-disordered breathing syndromes has been among the most rapidly evolving within the discipline of otolaryngology and head and neck surgery. An intrinsic sleep disorder that is often referred for an otolaryngologist’s evaluation is Obstructive sleep apnea hypopnea syndrome (OSAHS). Patients with OSAHS have an apnea-hypopnea index of more than five events per hour of sleep and usually have upper airway resistance and usually have accompanying loud snoring, sleep- disordered breathing, blood oxygen saturation decrease, excessive daytime sleepiness and other symptoms. Currently, OSAHS is considered to be the source of a variety of chronic systemic diseases. Insulin resistance is the pathophysiology foundation of Metabolic syndrome (MS). MS is composed of a series of syndromes such as hypertension, hyperglycemia, hyperlipemia and hyperuricacidemia, which are all risk factors of cardiovascular disease. MS is the most principal factor in the development of cardiovascular disease. More and more scholars have paid attention to the relationship between MS and OSAHS. Adiponectin levels and C-reactive protein (CRP) levels in serum are closely related to the metabolic syndrome. Adiponectin is one of the important regulatory factors in the regulation network of lipids metabolism and blood sugar homeostasis. It can reduce the level of blood sugar and blood fat and strengthen insulin resistance, anti-inflammatory and antagonistic role in atherosclerosis sclerosis. CRP level rising in serum can be used to assess the occurrence of acute complications and prognosis in atherosclerosis. Therefore, we can speculate that OSAHS may affect the adiponectin levels and CRP levels and the determination of adiponectin and CRP level may evaluate the risk of cardiovascular disease. In our study, we compared blood pressure, fasting serum glucose, blood fat, adiponectin, CRP in both OSAHS group and control group ,then discussed whether the obstructive sleep apnea hypopnea syndrome (OSAHS) was associated with the metabolic syndrome. Furthermore, we detected adiponectin levels and CRP levels in serum of OSAHS patients and analyzed whether their levels were relative to combined with MS.
Methods: According to apnea-hypopnea index (AHI), the OSAHS patients were divided into mild, moderate and severe groups: severe OSA (AHI>40, 21 males), moderate OSA (20
Conclusions: We investigated whether the components of metabolic syndrome were associated with OSAHS in nonobese patients. OSAHS is associated with the components of metabolic syndrome and its overall prevalence. The serum adiponectin levels were lower and the CRP levels were higher with the complication of the metabolic syndrome in OSAHS . Therefore, the complication of metabolic syndrome may become an additive cardiovascular risk factor in subjects with OSAHS.
引文
[1]中华医学会耳鼻咽喉科学分会 中华耳鼻咽喉科杂志编委会.阻塞性睡眠呼吸暂停低通气综合征诊断依据和疗效评定标准暨悬雍垂腭咽成形术适应征(杭州).中华耳鼻咽喉科杂志,2002,37(6):43-404
[2]陈名道.脂肪细胞产物与肥胖和代谢综合征[J].中华内分泌代谢杂志,2003,19:161-163.
[3]OuchiN, Kihara S, Funahashi T, et al.Reciprocal association of C - reactive protein with adiponectin in blood stream and adipose tissue[J]Circulation, 2003, 107 (5) : 671 – 4
[4]YiP HK, Hang CL, Fang CY, et al.Level of high - sensitivity C - reactive protein is predictive of 30 - day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention[J ]Chest, 2005, 127 (3) : 803 – 8
[5]中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志, 2004, 12(3): 156- 161.
[6]Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man [J].Diabetologia,1985,28(7):412-9
[7]Vgontzas AN, Bixler EO,Chrousos GP,et al. Sleep apenea is a manifestation of the metabolic syndrome [J].Sleep Medicine Reviews 2005,9(3):211-224
[8]Lam JC, Lam CL,Fong D,et al.Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong [J].Respir Med,2006,100(6):980-7
[9]Jurkovicoval I,Celec P.Sleep apnea syndrome and its complica tions. Acta Med Austriaca,2004,31;45-50
[10]Ohayon MM,Guilleminault C,Priest RG,et al. Is sleep-disorderedbreathing an independent risk factor for hypertension in the general population (13,057 subjects)?[J]. Psychosom Res,2000,48(6):593-601
[11]Lebovitz HE.The relationship of obesity to the metabolic syndrome [J].Int J Clin Pract Suppl,2003,Mar(134):18-27,Review.
[12]IP MS,Lam B,Ng MM,et al .obstructive sleep apnea is independently associated with insulin resisitance [J].Am J ResPir Crit Cate Med,2002, 165(5):670-6
[13]Harsch IA,Schahin SP,Radespiel-TrogerM,et al. Continuous Positive Airway Pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome [J].Am J Respir Crit Care Med,2004, 169: 156 - 62
[14]张希龙,殷凯生,王虹,等.阻塞性睡眠呼吸暂停低通气综合征与代谢综合征相关机制的探讨[J].中华结核和呼吸杂志,2004,27:647-8
[15]冯学威,何平,郑伟,等.阻塞性睡眠呼吸暂停低通气综合征病人睡眠时相改变与呼吸紊乱的关系。[J].中国全科医学,2006,9:881
[16]Wever C ,Funahashi T,Tanaka S ,et al. Hypoadiponectinemia in obesity and type 2 diabetes :close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab , 2001 ;86 (5):1930-5
[17]Lindsay RS ,Funahashi T,Hanson RL ,et al. Adiponection and development of type 2 diabetes in the Pima Indian population. Lancet , 2002 ;360(9326) :57-8
[18]Yamauchi T ,Kamon J ,Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[J ]. Nat Med ,2002 ,8(11) :1288-95.
[19]顾卫琼 ,洪洁 ,张翼飞 ,等. 肥胖人群中血清瘦素、游离脂肪酸和脂联素水平的相互关系[J]. 中华内分泌代谢杂志 ,2003 ,19(3) :169-172.
[20]Havel PJ . Control of energy homeostasis and insulin action by adipocyte hormones: leptin , acylation stimulating protein , and adiponectin [J].CurrOpin Lipidol ,2002 ;13(1) :51-9.
[21]Liu H ,Liu J ,Xiong S ,et al. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ ,2000 ;20(3) :200-2
[22]Fasshauer M,Klein J ,Neumann S ,et al. Hormonal regulation of adiponection gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun , 2002 ;290 (3):1084-9
[23]Fasshauer M,Kralisch S ,Klier M,et al. Adiponection gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.Biochem Biophys Res Commun ,2003 ;301 (4):1045-50
[24]Yip HK, Hang CL, Fang CY, et al. Level of high - sensitivity C-reactive protein is predictive of 30 - day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention[J]Chest, 2005, 127 (3) : 803 - 808
[25]Shioji K, Moriwaki S, Takeuchi Y, et al.Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention [J] Circulation, 2007, 71(5) : 675 - 80
[1]中华医学会耳鼻咽喉科学分会 中华耳鼻咽喉科杂志编委会.阻塞性睡眠呼吸暂停低通气综合征诊断依据和疗效评定标准暨悬雍垂腭咽成形术适应征(杭州).中华耳鼻咽喉科杂志,2002,37(6):403-404
[2]World Health Organization.Definition,diagnosisand classification of diabetes mellitus and its complication [R].WHO/NCD/NCS,1999:31-32.
[3]Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the Third Report of the National Cholesterol Education Program(NCEP) Expert panel on detection,evaluation,and treatment of high Blood cholesterol in adults(Adult Treatment Panel Ⅲ)[J].JAMA,2001,285: 2486-97.
[4]中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志,2004,12(3):156-161.
[5] Hills SA , Balkau B , Coppack SW , et al. The EGIR-RISCSTUDY ( The European group for the study of insulin resistance : relationship between insulin sensitivity and cardiovascular disease risk) : I. Methodology and objectives [J ]. Diabetologia , 2004 ,47 (3): 566 - 570.
[6]Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte[J]. Int J Obes Relat Metab Disord ,2000 ,24(Suppl 4) :S23-S27.
[7] Yamauchi T ,Kamon J ,Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[J ]. Nat Med ,2002 ,8(11) :1288-95.
[8]顾卫琼 ,洪洁 ,张翼飞 ,等. 肥胖人群中血清瘦素、游离脂肪酸和脂联素水平的相互关系[J ]. 中华内分泌代谢杂志 ,2003 ,19(3) :169-172.
[9]Havel PJ . Control of energy homeostasis and insulin action by adipocytehormones: leptin , acylation stimulating protein , and adiponectin [J].Curr Opin Lipidol ,2002 ,13(1) :51-9.
[10]Grote L,Hedne J,Peter JH.Mean blood pressure,pulse Pressure and grade of hypertension in untreated hypertension Patients with sleep-related breathing disorder.J Hypertens,2001,19(4):683-90.
[11]Lologan AG,Perilikowski SM,Mente A,et al.High prevalence of unrecognized sleep apnea in drug resistant hypertension.J Hypertens,2001, 19(12):2271-7.
[12]Imadojemu VA,Gleeson K,Quraishi SA,et al,Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy.Am J Respir Crit Care Med,2002,165(7):950-3
[13]Lavie P,Herer P,Hoffstein V.Obstructive sleep apnea syndrome as a risk factor for hypertension:population study.Br Med J,2000, 320(7233): 479-82
[14]Davies CW,Crosby JH,Mullins RL,et al.Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnea and normal matched control subjects.Thorax,2000, 55(9): 736- 40.
[15]Koehler U, Schafer H. Is obstrictove sleep apnea.(OSA) a risk fcctor for myocardial infarction and Cardiac arrhythmias in patients with coronary heart disease(CHD) ?[J].Sleep, 1996, 19(4): 283-6.
[16]Jurkovicoval,Celec P.Sleep apnea syndrome and its complications.Acta Med Austriaca,2004,31(3);45-50,Review.
[17]Ryan CF, Love LL. Mechanical properties of the velopharynx in obese patients with obstrutive sleep apnea [J]. Am J Rsepir Crit Care Med, 1996, 154(3): 806-12.
[18]Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstrutive sleep apneahormones: leptin , acylation stimulating protein , and adiponectin [J].Curr Opin Lipidol ,2002 ,13(1) :51-9.
[10]Grote L,Hedne J,Peter JH.Mean blood pressure,pulse Pressure and grade of hypertension in untreated hypertension Patients with sleep-related breathing disorder.J Hypertens,2001,19(4):683-90.
[11]Lologan AG,Perilikowski SM,Mente A,et al.High prevalence of unrecognized sleep apnea in drug resistant hypertension.J Hypertens,2001, 19(12):2271-7.
[12]Imadojemu VA,Gleeson K,Quraishi SA,et al,Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy.Am J Respir Crit Care Med,2002,165(7):950-3
[13]Lavie P,Herer P,Hoffstein V.Obstructive sleep apnea syndrome as a risk factor for hypertension:population study.Br Med J,2000, 320(7233): 479-82
[14]Davies CW,Crosby JH,Mullins RL,et al.Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnea and normal matched control subjects.Thorax,2000, 55(9): 736- 40.
[15]Koehler U, Schafer H. Is obstrictove sleep apnea.(OSA) a risk fcctor for myocardial infarction and Cardiac arrhythmias in patients with coronary heart disease(CHD) ?[J].Sleep, 1996, 19(4): 283-6.
[16]Jurkovicoval,Celec P.Sleep apnea syndrome and its complications.Acta Med Austriaca,2004,31(3);45-50,Review.
[17]Ryan CF, Love LL. Mechanical properties of the velopharynx in obese patients with obstrutive sleep apnea [J]. Am J Rsepir Crit Care Med, 1996, 154(3): 806-12.
[18]Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstrutive sleep apnea
[28]Liu H, Liu J, Xiong S,et al.The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome . J Tongji Med Univ, 2000, 20 (3):200-2.
[29]Gianotti L, Pivetti S, Lanfranco F, et al. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patiens with obstructive sleep apnea syndrome.J Clin Endocrinol Merab, 2002, 87 (11): 5052-7.
[30]Baylor P,Mouton A,Goebel P et al. Increased norepinephrine variability in patients with sleep apnea syndrome. Am J Med, 1995, 99 (6): 611-5.
[31]Takahashi M,Arita Y,Yamagata K,et al.Genomic structure and mutations in adipose-specific gene, adiponectin [J].Int J Obes Relat Metab Disord, 2000, 24 (7):861-8.
[32]Maeda N,Takahashi M,Funahashi T,et al.PPARgama ligands increase expression and plasma concentration of adiponectin,an adipose-derived protein. Diabete, 2001, 50(9):2094-9
[33]陈名道.脂肪细胞产物与肥胖和代谢综合征[J].中华内分泌代谢杂志,2003,19:161-163.
[34]Yang WS,Lee WJ,et al.Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein,adiponetion,J Clin Endocrinol Metab,2001,86(8):3815-9
[35]王遂军,贾伟军,包玉清等.血清脂联素与肥胖的关系[J].中华内分泌代谢杂志,2005,21:36-38
[36]Goldstein BJ,Scalia R, et al .Adiponectin:A novel adipokine linking adipocytes and vascular function.J Clin Endocrinol Merab, 2004, 89: 2563-8
[37]刘军,李英等,高甘油三脂血症患者脂联素水平与胰岛素抵抗相关性研究,实用糖尿病杂志,2005,1(5):37-39
[38]Iwashima Y,Katsuya T, et al.Hypoadiponectinemia is an independent riskfactor for hypertension.[J].Hypertension, 2004, 43(6): 1318- 23
[39]李小平等,高血压并患者血清脂联素水平的研究[J]中华心血管病杂志,2004,32(7):596-599
[40]Cesari M, Pessina AC,Zanchetta M, et al.Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high-risk nondiabetic patients. [J]. J Intern Med. 2006 Nov;260(5):474-83
[41]朱翠英,王青,韩源等,脂联素与 2 型糖尿病的关系[J]标记免疫分析与临床,200714(2);73-75
[42]Weyer C,Funahashi T,Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinemia.J Clin Endpcrinol Metab, 2001, 86 (5):1930-5.
[43] von Eynatten M, Hamann A, Twardella D,et al. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease [J]. Clin Chem. 2006 May;52(5):853-9
[44]Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice [J].Proc Natl Acad Sci USA, 2001, 98 (4): 2005-2010.
[45]Combs TP, Berg AH, Obici S, et al.Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.J Clin Invest, 2001, 108 (12):1875-81.
[46]Berg AH, Combs TP, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action .Nat Med, 2001, 7 (8): 947-53.
[47]Matsuda M,Shimomura I,Sata M,et al. Role of adiponectin in preventing vascular stenosis.the missing link of adipo-vascular axis.J Biol Chem,2002, 277 (40):37487-91.
[48]于晖,娄可佳等,C 反应蛋白与肥胖的关系的研究,中国分子心脏病学杂志,2005,5(4):609-611
[49]Tamakoshi K,Yatsuya H,Kondo T,et al.The metabolic syndrome is assoaciated with elevated circulating C-reactive protein in healthy reference range,a systemic Low-grade inflammatory state.Int J Obes Relat Metab Disord,2003,27(4):443-9
[50]Weng ND,Pio J,Valencia R,et al.Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey(NHANES)Ⅲ.Prev Cardiol,2001,4(3):109-114
[51]Sesso HD ,Buring JE,Rifai N,et al.C-reactive protein and the risk of developing hypertension[J]. JAMA,2003, 290(22): 2945 -51
[52]Ford ES,Body mass index,diabetes,and C-reactive protein among U.S.adults. [J].Diabetes Care,1999,22(12):1971-7
[53]Festa A,D'Agostino R Jr,Howard G,et al.Chronic subclinical inflammation as part of the insulin resistance Syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).Circulation,2000,102(1):42-7
[54]Melaughlin T,Abbasi F,Lamendola C,et al.Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation, 2002, 106(23):2908-12
[55]Barzilay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study[J].Diabetes ,2001,50 (10):2384-9
[56]Freeman DJ,Norrie J,Caslake MJ,et al.C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study[J]. Diabetes, 2002, 51(5):1596-600
[57]Ridker PM,Rifai N,Rose L.et al.Comparision of C-reactive protein andlow-density lipoprotein cholesterol Levels in the prediction of first cardiovascular events.N Eng J Med,2002,347(20),1557-65
[58]Ouchi N, Kihara S, Funahashi T, et al.Reciprocal association of C -reactive protein with adiponectin in blood stream and adipose tissue. [J]Circulation, 2003, 107 (5) : 671 – 4
[59]Yip HK, Hang CL, Fang CY, et al. Level of high - sensitivity C -reactive protein is predictive of 30 -day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.[J] Chest, 2005, 127 (3) : 803 - 8
[2]陈名道.脂肪细胞产物与肥胖和代谢综合征[J].中华内分泌代谢杂志,2003,19:161-163.
[3]OuchiN, Kihara S, Funahashi T, et al.Reciprocal association of C - reactive protein with adiponectin in blood stream and adipose tissue[J]Circulation, 2003, 107 (5) : 671 – 4
[4]YiP HK, Hang CL, Fang CY, et al.Level of high - sensitivity C - reactive protein is predictive of 30 - day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention[J ]Chest, 2005, 127 (3) : 803 – 8
[5]中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志, 2004, 12(3): 156- 161.
[6]Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man [J].Diabetologia,1985,28(7):412-9
[7]Vgontzas AN, Bixler EO,Chrousos GP,et al. Sleep apenea is a manifestation of the metabolic syndrome [J].Sleep Medicine Reviews 2005,9(3):211-224
[8]Lam JC, Lam CL,Fong D,et al.Obstructive sleep apnea and the metabolic syndrome in community-based Chinese adults in Hong Kong [J].Respir Med,2006,100(6):980-7
[9]Jurkovicoval I,Celec P.Sleep apnea syndrome and its complica tions. Acta Med Austriaca,2004,31;45-50
[10]Ohayon MM,Guilleminault C,Priest RG,et al. Is sleep-disorderedbreathing an independent risk factor for hypertension in the general population (13,057 subjects)?[J]. Psychosom Res,2000,48(6):593-601
[11]Lebovitz HE.The relationship of obesity to the metabolic syndrome [J].Int J Clin Pract Suppl,2003,Mar(134):18-27,Review.
[12]IP MS,Lam B,Ng MM,et al .obstructive sleep apnea is independently associated with insulin resisitance [J].Am J ResPir Crit Cate Med,2002, 165(5):670-6
[13]Harsch IA,Schahin SP,Radespiel-TrogerM,et al. Continuous Positive Airway Pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome [J].Am J Respir Crit Care Med,2004, 169: 156 - 62
[14]张希龙,殷凯生,王虹,等.阻塞性睡眠呼吸暂停低通气综合征与代谢综合征相关机制的探讨[J].中华结核和呼吸杂志,2004,27:647-8
[15]冯学威,何平,郑伟,等.阻塞性睡眠呼吸暂停低通气综合征病人睡眠时相改变与呼吸紊乱的关系。[J].中国全科医学,2006,9:881
[16]Wever C ,Funahashi T,Tanaka S ,et al. Hypoadiponectinemia in obesity and type 2 diabetes :close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab , 2001 ;86 (5):1930-5
[17]Lindsay RS ,Funahashi T,Hanson RL ,et al. Adiponection and development of type 2 diabetes in the Pima Indian population. Lancet , 2002 ;360(9326) :57-8
[18]Yamauchi T ,Kamon J ,Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[J ]. Nat Med ,2002 ,8(11) :1288-95.
[19]顾卫琼 ,洪洁 ,张翼飞 ,等. 肥胖人群中血清瘦素、游离脂肪酸和脂联素水平的相互关系[J]. 中华内分泌代谢杂志 ,2003 ,19(3) :169-172.
[20]Havel PJ . Control of energy homeostasis and insulin action by adipocyte hormones: leptin , acylation stimulating protein , and adiponectin [J].CurrOpin Lipidol ,2002 ;13(1) :51-9.
[21]Liu H ,Liu J ,Xiong S ,et al. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ ,2000 ;20(3) :200-2
[22]Fasshauer M,Klein J ,Neumann S ,et al. Hormonal regulation of adiponection gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun , 2002 ;290 (3):1084-9
[23]Fasshauer M,Kralisch S ,Klier M,et al. Adiponection gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes.Biochem Biophys Res Commun ,2003 ;301 (4):1045-50
[24]Yip HK, Hang CL, Fang CY, et al. Level of high - sensitivity C-reactive protein is predictive of 30 - day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention[J]Chest, 2005, 127 (3) : 803 - 808
[25]Shioji K, Moriwaki S, Takeuchi Y, et al.Relationship of serum adiponectin level to adverse cardiovascular events in patients who undergo percutaneous coronary intervention [J] Circulation, 2007, 71(5) : 675 - 80
[1]中华医学会耳鼻咽喉科学分会 中华耳鼻咽喉科杂志编委会.阻塞性睡眠呼吸暂停低通气综合征诊断依据和疗效评定标准暨悬雍垂腭咽成形术适应征(杭州).中华耳鼻咽喉科杂志,2002,37(6):403-404
[2]World Health Organization.Definition,diagnosisand classification of diabetes mellitus and its complication [R].WHO/NCD/NCS,1999:31-32.
[3]Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the Third Report of the National Cholesterol Education Program(NCEP) Expert panel on detection,evaluation,and treatment of high Blood cholesterol in adults(Adult Treatment Panel Ⅲ)[J].JAMA,2001,285: 2486-97.
[4]中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志,2004,12(3):156-161.
[5] Hills SA , Balkau B , Coppack SW , et al. The EGIR-RISCSTUDY ( The European group for the study of insulin resistance : relationship between insulin sensitivity and cardiovascular disease risk) : I. Methodology and objectives [J ]. Diabetologia , 2004 ,47 (3): 566 - 570.
[6]Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte[J]. Int J Obes Relat Metab Disord ,2000 ,24(Suppl 4) :S23-S27.
[7] Yamauchi T ,Kamon J ,Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[J ]. Nat Med ,2002 ,8(11) :1288-95.
[8]顾卫琼 ,洪洁 ,张翼飞 ,等. 肥胖人群中血清瘦素、游离脂肪酸和脂联素水平的相互关系[J ]. 中华内分泌代谢杂志 ,2003 ,19(3) :169-172.
[9]Havel PJ . Control of energy homeostasis and insulin action by adipocytehormones: leptin , acylation stimulating protein , and adiponectin [J].Curr Opin Lipidol ,2002 ,13(1) :51-9.
[10]Grote L,Hedne J,Peter JH.Mean blood pressure,pulse Pressure and grade of hypertension in untreated hypertension Patients with sleep-related breathing disorder.J Hypertens,2001,19(4):683-90.
[11]Lologan AG,Perilikowski SM,Mente A,et al.High prevalence of unrecognized sleep apnea in drug resistant hypertension.J Hypertens,2001, 19(12):2271-7.
[12]Imadojemu VA,Gleeson K,Quraishi SA,et al,Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy.Am J Respir Crit Care Med,2002,165(7):950-3
[13]Lavie P,Herer P,Hoffstein V.Obstructive sleep apnea syndrome as a risk factor for hypertension:population study.Br Med J,2000, 320(7233): 479-82
[14]Davies CW,Crosby JH,Mullins RL,et al.Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnea and normal matched control subjects.Thorax,2000, 55(9): 736- 40.
[15]Koehler U, Schafer H. Is obstrictove sleep apnea.(OSA) a risk fcctor for myocardial infarction and Cardiac arrhythmias in patients with coronary heart disease(CHD) ?[J].Sleep, 1996, 19(4): 283-6.
[16]Jurkovicoval,Celec P.Sleep apnea syndrome and its complications.Acta Med Austriaca,2004,31(3);45-50,Review.
[17]Ryan CF, Love LL. Mechanical properties of the velopharynx in obese patients with obstrutive sleep apnea [J]. Am J Rsepir Crit Care Med, 1996, 154(3): 806-12.
[18]Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstrutive sleep apneahormones: leptin , acylation stimulating protein , and adiponectin [J].Curr Opin Lipidol ,2002 ,13(1) :51-9.
[10]Grote L,Hedne J,Peter JH.Mean blood pressure,pulse Pressure and grade of hypertension in untreated hypertension Patients with sleep-related breathing disorder.J Hypertens,2001,19(4):683-90.
[11]Lologan AG,Perilikowski SM,Mente A,et al.High prevalence of unrecognized sleep apnea in drug resistant hypertension.J Hypertens,2001, 19(12):2271-7.
[12]Imadojemu VA,Gleeson K,Quraishi SA,et al,Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy.Am J Respir Crit Care Med,2002,165(7):950-3
[13]Lavie P,Herer P,Hoffstein V.Obstructive sleep apnea syndrome as a risk factor for hypertension:population study.Br Med J,2000, 320(7233): 479-82
[14]Davies CW,Crosby JH,Mullins RL,et al.Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnea and normal matched control subjects.Thorax,2000, 55(9): 736- 40.
[15]Koehler U, Schafer H. Is obstrictove sleep apnea.(OSA) a risk fcctor for myocardial infarction and Cardiac arrhythmias in patients with coronary heart disease(CHD) ?[J].Sleep, 1996, 19(4): 283-6.
[16]Jurkovicoval,Celec P.Sleep apnea syndrome and its complications.Acta Med Austriaca,2004,31(3);45-50,Review.
[17]Ryan CF, Love LL. Mechanical properties of the velopharynx in obese patients with obstrutive sleep apnea [J]. Am J Rsepir Crit Care Med, 1996, 154(3): 806-12.
[18]Chin K, Shimizu K, Nakamura T, et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstrutive sleep apnea
[28]Liu H, Liu J, Xiong S,et al.The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome . J Tongji Med Univ, 2000, 20 (3):200-2.
[29]Gianotti L, Pivetti S, Lanfranco F, et al. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patiens with obstructive sleep apnea syndrome.J Clin Endocrinol Merab, 2002, 87 (11): 5052-7.
[30]Baylor P,Mouton A,Goebel P et al. Increased norepinephrine variability in patients with sleep apnea syndrome. Am J Med, 1995, 99 (6): 611-5.
[31]Takahashi M,Arita Y,Yamagata K,et al.Genomic structure and mutations in adipose-specific gene, adiponectin [J].Int J Obes Relat Metab Disord, 2000, 24 (7):861-8.
[32]Maeda N,Takahashi M,Funahashi T,et al.PPARgama ligands increase expression and plasma concentration of adiponectin,an adipose-derived protein. Diabete, 2001, 50(9):2094-9
[33]陈名道.脂肪细胞产物与肥胖和代谢综合征[J].中华内分泌代谢杂志,2003,19:161-163.
[34]Yang WS,Lee WJ,et al.Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein,adiponetion,J Clin Endocrinol Metab,2001,86(8):3815-9
[35]王遂军,贾伟军,包玉清等.血清脂联素与肥胖的关系[J].中华内分泌代谢杂志,2005,21:36-38
[36]Goldstein BJ,Scalia R, et al .Adiponectin:A novel adipokine linking adipocytes and vascular function.J Clin Endocrinol Merab, 2004, 89: 2563-8
[37]刘军,李英等,高甘油三脂血症患者脂联素水平与胰岛素抵抗相关性研究,实用糖尿病杂志,2005,1(5):37-39
[38]Iwashima Y,Katsuya T, et al.Hypoadiponectinemia is an independent riskfactor for hypertension.[J].Hypertension, 2004, 43(6): 1318- 23
[39]李小平等,高血压并患者血清脂联素水平的研究[J]中华心血管病杂志,2004,32(7):596-599
[40]Cesari M, Pessina AC,Zanchetta M, et al.Low plasma adiponectin is associated with coronary artery disease but not with hypertension in high-risk nondiabetic patients. [J]. J Intern Med. 2006 Nov;260(5):474-83
[41]朱翠英,王青,韩源等,脂联素与 2 型糖尿病的关系[J]标记免疫分析与临床,200714(2);73-75
[42]Weyer C,Funahashi T,Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes:close association with insulin resistance and hyperinsulinemia.J Clin Endpcrinol Metab, 2001, 86 (5):1930-5.
[43] von Eynatten M, Hamann A, Twardella D,et al. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease [J]. Clin Chem. 2006 May;52(5):853-9
[44]Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice [J].Proc Natl Acad Sci USA, 2001, 98 (4): 2005-2010.
[45]Combs TP, Berg AH, Obici S, et al.Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.J Clin Invest, 2001, 108 (12):1875-81.
[46]Berg AH, Combs TP, Du X, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action .Nat Med, 2001, 7 (8): 947-53.
[47]Matsuda M,Shimomura I,Sata M,et al. Role of adiponectin in preventing vascular stenosis.the missing link of adipo-vascular axis.J Biol Chem,2002, 277 (40):37487-91.
[48]于晖,娄可佳等,C 反应蛋白与肥胖的关系的研究,中国分子心脏病学杂志,2005,5(4):609-611
[49]Tamakoshi K,Yatsuya H,Kondo T,et al.The metabolic syndrome is assoaciated with elevated circulating C-reactive protein in healthy reference range,a systemic Low-grade inflammatory state.Int J Obes Relat Metab Disord,2003,27(4):443-9
[50]Weng ND,Pio J,Valencia R,et al.Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the National Health and Nutrition Examination Survey(NHANES)Ⅲ.Prev Cardiol,2001,4(3):109-114
[51]Sesso HD ,Buring JE,Rifai N,et al.C-reactive protein and the risk of developing hypertension[J]. JAMA,2003, 290(22): 2945 -51
[52]Ford ES,Body mass index,diabetes,and C-reactive protein among U.S.adults. [J].Diabetes Care,1999,22(12):1971-7
[53]Festa A,D'Agostino R Jr,Howard G,et al.Chronic subclinical inflammation as part of the insulin resistance Syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).Circulation,2000,102(1):42-7
[54]Melaughlin T,Abbasi F,Lamendola C,et al.Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation, 2002, 106(23):2908-12
[55]Barzilay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study[J].Diabetes ,2001,50 (10):2384-9
[56]Freeman DJ,Norrie J,Caslake MJ,et al.C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study[J]. Diabetes, 2002, 51(5):1596-600
[57]Ridker PM,Rifai N,Rose L.et al.Comparision of C-reactive protein andlow-density lipoprotein cholesterol Levels in the prediction of first cardiovascular events.N Eng J Med,2002,347(20),1557-65
[58]Ouchi N, Kihara S, Funahashi T, et al.Reciprocal association of C -reactive protein with adiponectin in blood stream and adipose tissue. [J]Circulation, 2003, 107 (5) : 671 – 4
[59]Yip HK, Hang CL, Fang CY, et al. Level of high - sensitivity C -reactive protein is predictive of 30 -day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.[J] Chest, 2005, 127 (3) : 803 - 8